Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Environment
Shantha Gets Vaccines Contracts
by Ann M. Thayer
September 7, 2009
| A version of this story appeared in
Volume 87, Issue 36
Shantha Biotechnics, part of Sanofi Pasteur, has been awarded $340 million in contracts from the United Nations to supply vaccines between 2010 and 2012. For the past few years, Shantha has worked with international organizations to provide vaccines to markets including Asia-Pacific, Africa, and Latin America. The company will supply a pentavalent vaccine that covers diphtheria, pertussis, tetanus, Haemophilus influenza B, and hepatitis B. Just last week, Sanofi gained control of the Indian vaccine maker by acquiring ShanH, which has a majority stake in Shantha.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter